CB LIN Tablet 2's

CB LIN Tablet 2's contains the active ingredient of cabergoline. This medicine belongs to a class of drugs called 'dopamine agonists.' Dopamine is naturally formed in the body and helps to send signals to the brain, which treats hyperprolactinemia (high levels of prolactin, a natural substance that allows breast development and milk production in women). CB LIN Tablet 2's helps stop breast milk production soon after stillbirth, abortion, miscarriage, or even after delivery if you do not want to breastfeed your baby once you have started.

Besides this, CB LIN Tablet 2's can also be used to treat other conditions caused by the hormonal disruption that can lead to the production of high levels of prolactin. This includes lack of periods, infrequent and very light menstruation, periods when there is no ovulation, and the secretion of milk from your breast without breastfeeding, even in conditions where high prolactin levels are caused by unknown causes (idiopathic hyperprolactinemia) or pituitary gland tumours in both men and women.

Take CB LIN Tablet 2's with food or after meals to avoid nausea and vomiting. Take CB LIN Tablet 2's in dose and duration prescribed by your doctor. Never encourage self-medication or suggest your medicine to someone else. Like all medicines, CB LIN Tablet 2's can cause side effects, although not everybody gets them. In some cases, you may experience blurred vision, drowsiness, constipation, vomiting, dizziness, headache, and fatigue. Most of these side effects of CB LIN Tablet 2's are temporary, do not require medical attention, and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Do not take CB LIN Tablet 2's if you have uncontrolled hypertension, known hypersensitivity to ergot derivatives, and heart disease as it is known to contraindicate. Tell your doctor if you are pregnant, planning pregnancy, breastfeeding, or having kidney or liver problems. CB LIN Tablet 2's should not be used in females below the age of 16 years. Also, try other forms of contraception, as hormonal conditions may not be effective. Regular blood pressure monitoring is required while you take CB LIN Tablet 2's.

CB LIN Tablet 2's contains cabergoline; the advantage of taking it is that it will reduce the level of prolactin in your blood and the effects you have encountered. It works by increasing the brain chemical called dopamine, which decreases the amount of prolactin released. Besides this, CB LIN Tablet 2's can also be used to treat other conditions caused by the hormonal disruption that can lead to the production of high levels of prolactin. This includes lack of periods, infrequent and very light menstruation, periods when there is no ovulation, and the secretion of milk from your breast without breastfeeding.

• Drowsiness
• Nausea
• Headache
• Dizziness
• Vertigo
• Stomach Pain
• Indigestion
• Inflamed Stomach Lining
• Fatigue
• Lack of bodily strength
• Weakness
• Constipation
• Blurred Vision
• Low Blood Pressure
• Breast Pain
• Depression
• Sleep Disturbances
• Excessive daytime drowsiness/Sleepiness
• Vomiting
• Hot Flushes

CB LIN Tablet 2's should not be taken if you are allergic to dopamine agonists or any of the ingredients of CB LIN Tablet 2's. Tell your doctor if you are pregnant, planning pregnancy, breastfeeding, or having kidney or liver problems. Please inform your doctor about all the other medications you are taking as they might affect how CB LIN Tablet 2's works. CB LIN Tablet 2's should not be used in females below the age of 16 years. Also, try other forms of contraception, as hormonal conditions may not be effective. Do not take CB LIN Tablet 2's if you have ever had uncontrolled hypertension, known hypersensitivity to ergot derivatives or heart disease as it is known to contra-indicate. Regular blood pressure monitoring is required while you take CB LIN Tablet 2's.

Drug-drug interactions: This medicine may interact with medications used to treat mental illness (chlorpromazine, haloperidol), nausea and vomiting (domperidone, metoclopramide clopramide), drugs for Parkinson’s disease, medicines for severe migraine headaches (bromocriptine, ergotamine, dihydroergotamine), antibiotics (erythromycin), schizophrenia (phenothiazines, thioxanthene).

Drug-Food Interactions: CB LIN Tablet 2's interacts with non-prescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take.

Drug-Disease Interactions: Inform your doctor if you have had high blood pressure, heart disease, kidney or liver problem, or mental illness.

• CHLORPROMAZINE
• HALOPERIDOL
• DOMPERIDONE
• METOCLOPRAMIDE
• BROMOCRIPTINE
• ERGOTAMINE
• DIHYDROERGOTAMINE
• ERYTHROMYCIN
• PHENOTHIAZINE

• Avoid alcoholic beverages with CB LIN Tablet 2's as they can make you feel dizzy and dehydrated and may affect your sleep.
• Monitor your blood sugar level as it is known to lower blood prolactin levels.
• Quit smoking as smoking increases the heart rate and may progress a heart ailment.
• Including heart-healthy omega-3 fatty acid-containing food drinks in your daily diet. You can also use low-fat cooking oil like olive oil, soybean oil, canola oil, and coconut oil.
• Eat a healthy balanced diet, including plenty of fluids, vegetables, proteins, and fat-free or low-fat dairy products. It will also help reduce weight and lower the heart attack risk. 
• Regular exercise keeps the mind thoughtful and lowers your stress level, thus reducing the prolactin level.

• Monitor your blood pressure, kidney, and liver function test regularly.

Hyperprolactinemia is a condition in which a person has higher-than-normal levels of the hormone prolactin in the blood. It causes infertility, decreased sex drive, and bone loss. In addition, women may have vaginal dryness, leading to pain during intercourse, Problems with menstruation, having no periods or irregular periods, and breast milk production when not pregnant or nursing. Erectile dysfunction—trouble getting or keeping an erection. Breast enlargement and decreased muscle mass and body hair may be observed in men.